Acer Therapeutics Price History

ACERDelisted Stock  USD 0.84  0.02  2.33%   
If you're considering investing in Acer Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acer Therapeutics stands at 0.84, as last reported on the 16th of December 2024, with the highest price reaching 0.86 and the lowest price hitting 0.83 during the day. We have found twenty-three technical indicators for Acer Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Acer Therapeutics' risk adjusted performance of (0.03), and Mean Deviation of 3.35 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Acer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ACER
Based on monthly moving average Acer Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acer Therapeutics by adding Acer Therapeutics to a well-diversified portfolio.

Acer Therapeutics Stock Price History Chart

There are several ways to analyze Acer Stock price data. The simplest method is using a basic Acer candlestick price chart, which shows Acer Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Acer Stock Price History Data

The price series of Acer Therapeutics for the period between Tue, Sep 17, 2024 and Mon, Dec 16, 2024 has a statistical range of 0.29 with a coefficient of variation of 8.02. The prices are distributed with arithmetic mean of 0.87. The median price for the last 90 days is 0.87. The company had 96:1000 stock split on 21st of September 2017. Acer Therapeutics issued dividends on 2017-09-21.
OpenHighLowCloseVolume
12/16/2024
 0.86  0.86  0.83  0.84 
07/24/2023 0.86  0.86  0.83  0.84  44,554 
07/21/2023 0.88  0.88  0.83  0.84  67,250 
07/20/2023 0.84  0.89  0.84  0.89  39,640 
07/19/2023 0.83  0.86  0.83  0.85  49,324 
07/18/2023 0.86  0.86  0.85  0.86  43,978 
07/17/2023 0.86  0.86  0.82  0.86  103,487 
07/14/2023 0.82  0.82  0.78  0.81  167,291 
07/13/2023 0.82  0.86  0.79  0.83  146,812 
07/12/2023 0.86  0.88  0.81  0.83  146,965 
07/11/2023 0.89  0.91  0.85  0.89  109,833 
07/10/2023 0.88  0.92  0.85  0.90  119,306 
07/07/2023 0.88  0.93  0.85  0.89  176,718 
07/06/2023 0.95  0.95  0.89  0.90  74,099 
07/05/2023 0.93  0.99  0.91  0.93  69,713 
07/03/2023 0.94  1.00  0.92  0.94  69,983 
06/30/2023 0.85  0.93  0.85  0.92  85,526 
06/29/2023 0.84  0.87  0.83  0.86  94,487 
06/28/2023 0.84  0.88  0.81  0.83  128,741 
06/27/2023 0.85  0.91  0.80  0.84  109,145 
06/26/2023 0.89  0.94  0.78  0.87  352,672 
06/23/2023 0.92  0.92  0.88  0.88  104,092 
06/22/2023 0.91  0.95  0.88  0.91  116,374 
06/21/2023 0.93  0.95  0.90  0.90  92,304 
06/20/2023 0.85  0.96  0.84  0.93  305,398 
06/16/2023 0.89  0.89  0.82  0.82  284,917 
06/15/2023 1.00  1.00  0.86  0.87  298,425 
06/14/2023 1.00  1.01  0.98  0.98  134,942 
06/13/2023 0.99  1.04  0.99  1.00  182,623 
06/12/2023 0.97  1.00  0.96  0.99  181,325 
06/09/2023 0.95  0.97  0.93  0.96  132,656 
06/08/2023 1.04  1.09  0.93  0.94  1,087,087 
06/07/2023 0.94  1.15  0.90  1.00  333,779 
06/06/2023 0.86  0.92  0.86  0.91  137,170 
06/05/2023 0.91  0.92  0.85  0.88  151,823 
06/02/2023 0.86  0.90  0.85  0.89  89,890 
06/01/2023 0.89  0.91  0.86  0.86  219,990 
05/31/2023 0.90  0.90  0.85  0.89  78,385 
05/30/2023 0.92  0.92  0.85  0.90  116,778 
05/26/2023 0.87  0.91  0.84  0.91  91,887 
05/25/2023 0.88  0.89  0.82  0.84  115,145 
05/24/2023 0.85  1.03  0.85  0.90  746,022 
05/23/2023 0.85  0.87  0.81  0.85  154,714 
05/22/2023 0.80  0.84  0.79  0.84  220,425 
05/19/2023 0.75  0.83  0.75  0.83  143,074 
05/18/2023 0.80  0.83  0.75  0.75  164,831 
05/17/2023 0.78  0.85  0.77  0.81  340,772 
05/16/2023 0.76  0.79  0.74  0.78  252,012 
05/15/2023 0.80  0.84  0.72  0.76  292,613 
05/12/2023 0.76  0.77  0.74  0.76  297,568 
05/11/2023 0.77  0.77  0.74  0.76  136,466 
05/10/2023 0.77  0.80  0.75  0.76  118,284 
05/09/2023 0.77  0.78  0.72  0.76  162,333 
05/08/2023 0.78  0.78  0.75  0.77  126,724 
05/05/2023 0.76  0.78  0.75  0.76  225,211 
05/04/2023 0.79  0.80  0.75  0.76  131,656 
05/03/2023 0.82  0.85  0.77  0.77  275,432 
05/02/2023 0.85  0.87  0.80  0.81  107,614 
05/01/2023 0.88  0.90  0.85  0.85  164,515 
04/28/2023 0.88  0.91  0.85  0.88  148,527 
04/27/2023 0.91  0.95  0.88  0.88  197,529 

About Acer Therapeutics Stock history

Acer Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acer Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acer Therapeutics stock prices may prove useful in developing a viable investing in Acer Therapeutics
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts. Acer Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

Acer Therapeutics Stock Technical Analysis

Acer Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Acer Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Acer Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Acer Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Acer Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Acer Stock

If you are still planning to invest in Acer Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acer Therapeutics' history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm